ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532300 announcements Wockhardt announcements and dividends declared BSE

Wockhardt Complete list of announcements declared & dividend announcements by Wockhardt 532300

Wockhardt 532300 listed on BSE and deals in

Announcements and dividends declared by Wockhardt 532300

Kaynes Tech, Wockhardt, Persistent Systems shares fall up to 5% as broader markets tumble. What lies ahead?
The stock market saw marked declines on Monday, particularly among smallcap and midcap shares. Persistent Systems and National Aluminium Company experienced prominent losses, contributing to the negative performance of the Nifty Midcap 100 and Smallcap 100
Announcement as on 31 August 2026

Wockhardt Q1 results: Revenue rises 26% to ?929 cr, profit at ?107 cr
Pharmaceuticals firm Wockhardt Ltd on Monday reported a consolidated profit after tax of Rs 107 crore for the first quarter ended June 30, mainly due to strong revenue growth. The company had posted a consolidated net loss of Rs 108 crore in the correspond
Announcement as on 10 August 2026

Pharma in her DNA, Wockhardt scion ready for deep dive in the US
Zahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacterial infections and is a significant bet for the company. Zaynich's US approval marks a major breakthrough after decades
Announcement as on 10 June 2026

If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil Khorakiwala
Wockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected to generate .5-2 billion in peak annual sales within 4-6 years. Wockhardt aims for a 20% share of the AMR market. Th
Announcement as on 02 June 2026

Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?
Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for urinary tract infections. The company also reported a strong turnaround in its March quarter results. Revenue and prof
Announcement as on 02 June 2026

Announcements by Wockhardt first page | Next page |

532300 Wockhardt current price & indicator signals

Moving Averages for Wockhardt

  • 5Day Average: 1915.15
  • 12Day Average: 1887.8
  • 20Day Average: 1903.76
  • 50Day Average: 1908.74
  • 100Day Average: 1788.28
  • 150Day Average: 1630.38
  • 200Day Average: 1567.28

532300 Indicators & signals

Indicator MACD (12,26,9)

1900.16, 1903.2, -2.27
Indicator MACD is in negative zone

Indicator ADX (14)

4.9, 22.23, 24.52
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532300 Wockhardt are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Wed Sep 2026 1904.75 1837.00 to 1910.30 2.91% 15.43 times
01 Tue Sep 2026 1850.85 1834.50 to 1910.00 -1.74% 0.68 times
31 Mon Aug 2026 1883.55 1872.85 to 1979.85 -4.66% 0.65 times
28 Fri Aug 2026 1975.70 1966.20 to 2045.45 0.75% 3.06 times
27 Thu Aug 2026 1960.90 1872.30 to 1987.55 4.29% 1.42 times
26 Wed Aug 2026 1880.25 1875.00 to 1931.30 -0.88% 0.41 times
25 Tue Aug 2026 1896.85 1872.00 to 1914.00 -0.16% 0.37 times
24 Mon Aug 2026 1899.85 1868.50 to 1909.45 0.75% 0.5 times
21 Fri Aug 2026 1885.80 1830.15 to 1898.55 3.04% 0.62 times
20 Thu Aug 2026 1830.15 1825.50 to 1851.95 0.27% 0.31 times
19 Wed Aug 2026 1825.20 1815.30 to 1880.95 -1.86% 1.97 times
18 Tue Aug 2026 1859.75 1855.50 to 1901.95 -1.81% 3.84 times

Videos related to: 532300 announcements Wockhardt announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

532300 announcements Wockhardt announcements and dividends declared BSE

 

Back to top